Sentences with phrase «not at current price»

If the oddly named Kobo Aura Edition 2 had something new or better to offer, or if it was priced lower, it would make a lot more sense for it to replace the Glo HD, but not at the current price and configuration.

Since I'm a bit of a Honda person, having owned many good ones, I do find this NSX entertaining but not at current prices.

But not at current prices.

Not exact matches

However, they do not sell as they are marginally better than the current technology at a much higher price.

«The current pace of repricing in fed funds is not immediately problematic for the Fed and there is yet time to price more into the curve, though we'd argue that at the June meeting, it's likely the markets will have to come to grips with the possibility of a fourth hike in 2018 and price more appropriately,» Lyngen said.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost - reduction projects are implemented and changes in general economic and financial conditions.

Private equity firms have recognized for a while now that they can't just expect management teams to conduct business as usual at the current price environments to deliver the types of returns that people expect.

They will not reveal whether that supply has changed, but at current market price, those 146,893 bitcoins would translate to nearly $ 35 million.

«While their current offer is «premised» on NXP going at $ 110, they would of course not necessarily be precluded from making a new offer premised on the new NXP price.»

And the new, heftier cost won't hit everyone — existing Basecamp customers will be grandfathered in at their current prices.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

These risks include, in no particular order, the following: the trends toward more high - definition, on - demand and anytime, anywhere video will not continue to develop at its current pace or will expire; the possibility that our products will not generate sales that are commensurate with our expectations or that our cost of revenue or operating expenses may exceed our expectations; the mix of products and services sold in various geographies and the effect it has on gross margins; delays or decreases in capital spending in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact of general economic conditions on our sales and operations; our ability to develop new and enhanced products in a timely manner and market acceptance of our new or existing products; losses of one or more key customers; risks associated with our international operations; exchange rate fluctuations of the currencies in which we conduct business; risks associated with our CableOS ™ and VOS ™ product solutions; dependence on market acceptance of various types of broadband services, on the adoption of new broadband technologies and on broadband industry trends; inventory management; the lack of timely availability of parts or raw materials necessary to produce our products; the impact of increases in the prices of raw materials and oil; the effect of competition, on both revenue and gross margins; difficulties associated with rapid technological changes in our markets; risks associated with unpredictable sales cycles; our dependence on contract manufacturers and sole or limited source suppliers; and the effect on our business of natural disasters.

I looked at getting into Bitcoin back when it was 2300 a coin, now don't want to pay the current price compared what I could have paid..

At that price, not only are plans to double output from the oil sands no longer commercially viable, but current production levels also come into question.

The reality is that one doesn't need interest rates reasonably estimate 10 - year prospective market returns, just as one doesn't need interest rates to calculate that a $ 100 expected payment in 10 years, at a current price of $ 65, will result in an expected total return of 4.4 % over the coming decade.

Gold, iron ore and oil prices are seeing a rebound at the moment with many analysts believing that commodity prices have «bottomed out» and are eyeing gains, but Goldman Sachs has issued a warning on the current surge in commodities arguing that it is «not sustainable.»

We don't expect the coin to re-test its lows, as several strong support levels are below the current price level, at $ 51, $ 44, and $ 38.

(d) by causing Retrophin to pay cash to himself, Biestek, and Fernandez so that he would not have to invest $ 731,778 of his own funds in the February PIPE, and by using PIPE proceeds in contravention of the terms of the Securities Purchase Agreement to fund investments by Shkreli, Biestek and Fernandez, resulting in an additional benefit to Shkreli alone of $ 360,000 in cash and 180,000 Retrophin shares and warrants worth more than $ 5.3 million (at current market prices).

What is more, the closer the market gets to 4,500, the greater the gap between the current price of the index and the price at which the index would have traded had the implied call not existed.

Kinder Morgan Inc. (KMI)- Kinder Morgan is a company I've been reading a lot about recently and wouldn't mind adding it here at current prices where it currently trading at $ 31, down from its 52 week high of $ 41.49.

You can typically set your trailing stop - loss to trail at a certain distance from current market price, it will not start moving until or unless the price moves greater than the distance you specify.

Others will stand ready to buy the shares at the current market price, meaning supply and demand aren't helpful ways to think about stock prices.

I pass on probably 99 % of the ideas I look at, many of which are great businesses, simply because the current price won't allow my investment in the stock to compound at the rate of return that I'm -LSB-...]

At the current time, Pfizer is priced above my cost basis so I will not be looking to add anymore shares to my portfolio.

Because TRC's offer price is at a price below the current market price, Kraft Heinz recommends that stockholders not tender their shares (i.e., take no action) or, if they have already tendered shares, withdraw their shares by providing the written notice described in the TRC mini-tender offer documents prior to the expiration of the offer, currently scheduled for 12:01 a.m., New York City time, on Wednesday, December 14, 2016.

The SEC has cautioned investors that «some bidders make mini-tender offers at below - market prices, hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price.»

«Since we expect that: 1) the Chinese economy will continue to grow (cumulative GDP in current prices), 2) the export arbitrage is not showing any signs of contraction and 3) imports of steel will remain steady at about 1.2 million tons - per - month, we can safely assume that steel exports of 7.2 million tons - per - month and therefore a net trade balance of about 6 million tons - per - month will be around for a while.»

«We see Apple as a provider of premium priced electronics, a lucrative market but one that may not sustain its current market valuation of $ 473 billion in the years ahead,» Colin Gillis, an analyst at BGC Financial, wrote in a note to clients this week.

Actual results may vary materially from those expressed or implied by forward - looking statements based on a number of factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.

S&P 500 financials stand at a 15.5 x trailing ratio; thus, brokerage shares are not a bargain at current price levels.

Even if you have private information that I don't have, it's impossible to use it to make a profit because as soon as you try to buy, I infer that you must have information that the security is desirable at the current price.

For example, Fidelity will allow you to search both investment grade and junk bonds, show you the number of bonds available at both the bid and ask price, and will even allow you to submit a limit order (although you can not put in a good until cancelled order or one that is more than a small amount away from the current bid / ask).

When used as a trade replication tool, note that the new trade will open at the current market price, and not the old price associated with the original trade.

We are not so optimistic as to predict that our financial holdings will return to their pre-2008 profitability levels, but at current share prices we believe that the sector is still attractive.

As usual, I don't place too much emphasis on this sort of forecast, but to the extent that I make any comments at all about the outlook for 2006, the bottom line is this: 1) we can't rule out modest potential for stock appreciation, which would require the maintenance or expansion of already high price / peak earnings multiples; 2) we also should recognize an uncomfortably large potential for market losses, particularly given that the current bull market has now outlived the median and average bull, yet at higher valuations than most bulls have achieved, a flat yield curve with rising interest rate pressures, an extended period of internal divergence as measured by breadth and other market action, and complacency at best and excessive bullishness at worst, as measured by various sentiment indicators; 3) there is a moderate but still not compelling risk of an oncoming recession, which would become more of a factor if we observe a substantial widening of credit spreads and weakness in the ISM Purchasing Managers Index in the months ahead, and; 4) there remains substantial potential for U.S. dollar weakness coupled with «unexpectedly» persistent inflation pressures, particularly if we do observe economic weakness.

Despite being the industry leader, we'll show below that Mattress Firm is not an attractive acquisition target because unless a buyer is willing to destroy shareholder value, an acquisition at current prices would be unwise.

So now one could clearly challenge my «model» and tweak it somehow, but in general it looks like that GTT is not a bargain at current prices (34 EUR).

Therefore GTT at current prices is not interesting to me as an investment.

Hard rock deposits by and large are not economic at current spot (or term) uranium prices, so if you see uranium at $ 75 or $ 80 per pound in the coming years (I don't), purchasing shares in hard rock uranium development companies could lead to gains.

Pierre Lassonde, chairman of Franco - Nevada, argues that gold is priced fairly at current levels, but it won't truly enter a bull market again until prices climb much higher and, in hindsight, make now the time to buy gold before prices get another boost; and

With oil prices plummeting 4 percent at 12:33 pm EDT on Thursday, with WTI breaking below $ 50, it looks like a nine - month extension at current production levels is not enough to convince the market.

So that's a question that I don't think we know the answer to, but if millennials can't buy the boomers house at the current value than basic supply and demand economics suggests that prices will have to fall to the point at which they're affordable to millennials.

At current price levels we are just talking about lunacy here, not a means by which to get your money out of the country.

This means that blindly selling short $ QQQ (or buying an inversely correlated «short ETF») at the current price level of $ QQQ is risky and not advisable.

The only insight I can derive from the matter is that I would not invest in gold at the current time, and I believe the market price of gold could have significant downside if cryptocurrencies continue to gain in value.

Said simply, if you feel a business is overvalued you shouldn't buy a stock at its current price.

At its current level of profitability, Mattel is not worth buying at any pricAt its current level of profitability, Mattel is not worth buying at any pricat any price.

-- the current price at 12,35 EUR is ~ 1/3 lower than the expired take - over offer from Deutsche Annington 6 weeks ago — although the share will be delisted by the end of the year, I do believe that a squeeze - out under Luxembourg law is very likely within the next 12 - 18 months close to the initial offer price (~ 50 % upside from current price)-- the downside is that following November, the stock will be unlisted and hard to sell and that for some reason the Acquirer Deutsche Annington will not squeeze out the remaining minorities

The hedge funds also expressed concern that OPEC and Russia won't continue cutting oil production to keep prices high after the current deal expires at the end of the year.